Paper39749335
CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives.
Zhou J and 10 others. Front Immunol, 2024. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives. Papers, record 39749335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39749335
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lupus Erythematosus, Systemic | Major topic |
| Immunotherapy, Adoptive | Major topic |
| Receptors, Chimeric Antigen | Major topic |
| Humans | |
| Animals | |
| T-Lymphocytes | |
| B-Lymphocytes |
Source PubMed
References211
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20076604 | Distinct B cell receptor functions are determined by phosphorylation. | PLoS Biol | 2006 | https://conductscience.org/library/papers/20076604 | PubMed |
| 2 | 30448290 | Systemic lupus erythematosus: Diagnosis and clinical management. | J Autoimmun | 2019 | https://conductscience.org/library/papers/30448290 | PubMed |
| 3 | 11733573 | Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. | J Exp Med | 2001 | https://conductscience.org/library/papers/11733573 | PubMed |
| 4 | 11473831 | An etiopathogenic role for the type I IFN system in SLE. | Trends Immunol | 2001 | https://conductscience.org/library/papers/11473831 | PubMed |
| 5 | 26027434 | Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers. | J Autoimmun | 2015 | https://conductscience.org/library/papers/26027434 | PubMed |
| 6 | 23267025 | Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. | J Immunol | 2013 | https://conductscience.org/library/papers/23267025 | PubMed |
| 7 | 37343653 | Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4+ T cells via miR-29b-sp1/DNMT1 pathway in MRL/lpr mice. | J Ethnopharmacol | 2023 | https://conductscience.org/library/papers/37343653 | PubMed |
| 8 | 31180031 | Novel paradigms in systemic lupus erythematosus. | Lancet | 2019 | https://conductscience.org/library/papers/31180031 | PubMed |
| 9 | 38746066 | Hydroxychloroquine and the associated risk of arrhythmias. | Glob Cardiol Sci Pract | 2024 | https://conductscience.org/library/papers/38746066 | PubMed |
| 10 | 37171669 | Current treatment of systemic lupus erythematosus: a clinician's perspective. | Rheumatol Int | 2023 | https://conductscience.org/library/papers/37171669 | PubMed |
| 11 | 31900462 | 'Off-the-shelf' allogeneic CAR T cells: development and challenges. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/31900462 | PubMed |
| 12 | 38667277 | Immunotherapy of Hematological Malignancies of Human B-Cell Origin with CD19 CAR T Lymphocytes. | Cells | 2024 | https://conductscience.org/library/papers/38667277 | PubMed |
| 13 | 33307059 | Perinuclear anti-neutrophil cytoplasmic antibody in systemic lupus erythematosus indicates more severe condition. | Clin Biochem | 2021 | https://conductscience.org/library/papers/33307059 | PubMed |
| 14 | 37047548 | Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047548 | PubMed |
| 15 | 37228028 | Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials. | Rheumatology (Oxford) | 2024 | https://conductscience.org/library/papers/37228028 | PubMed |
| 16 | 37996128 | CAR T cells for treating autoimmune diseases. | RMD Open | 2023 | https://conductscience.org/library/papers/37996128 | PubMed |
| 17 | 34911705 | Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. | Ann Rheum Dis | 2022 | https://conductscience.org/library/papers/34911705 | PubMed |
| 18 | 30953162 | Treg cells in autoimmunity: from identification to Treg-based therapies. | Semin Immunopathol | 2019 | https://conductscience.org/library/papers/30953162 | PubMed |
| 19 | 33333233 | B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE). | Autoimmun Rev | 2021 | https://conductscience.org/library/papers/33333233 | PubMed |
| 20 | 35203496 | CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications. | Biomedicines | 2022 | https://conductscience.org/library/papers/35203496 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42960000 | Additional B-Lymphocyte Stimulator Inhibitors Treatment Facilitated Glucocorticoid Withdrawal in Lupus Nephritis Patients: A Real-World Retrospective Observational Single-Center Cohort Study. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42960000 | PubMed |
| 42621160 | Management of systemic lupus erythematosus and antiphospholipid syndrome during CAR-T therapy: insights from two clinical cases. | Immunooncol Technol | 2026 | https://conductscience.org/library/papers/42621160 | PubMed |
| 42374531 | Humanized biparatopic nanobody-based CAR-T cells overcome antigen-heterogeneity in multiple myeloma. | J Transl Med | 2026 | https://conductscience.org/library/papers/42374531 | PubMed |
| 42309556 | Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus. | Lupus Sci Med | 2026 | https://conductscience.org/library/papers/42309556 | PubMed |
| 42260211 | Cellular therapies in systemic lupus erythematosus: recent progress and future directions. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/42260211 | PubMed |
| 42244005 | Mesenchymal stromal cell therapy for systemic lupus erythematosus: mechanisms, clinical translation, and future directions. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42244005 | PubMed |
| 42179345 | Preconditioning determines engraftment and therapeutic efficacy of anti-CD19 CAR-T cells in murine lupus. | J Immunol | 2026 | https://conductscience.org/library/papers/42179345 | PubMed |
| 42134594 | Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion From the American Society for Transplantation and Cellular Therapy. | Transplant Cell Ther | 2026 | https://conductscience.org/library/papers/42134594 | PubMed |
| 41789058 | Taming autoimmune thyroiditis: cellular immunomodulation through MSCs, Tregs, and tolDCs. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789058 | PubMed |
| 41751350 | Upregulated ZBP1 Is Associated with B-Cell Dysregulation in Systemic Lupus Erythematosus. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751350 | PubMed |
| 41648089 | What's New in Cutaneous Lupus Erythematosus: Guidelines, Biologics, and Beyond. | J Clin Aesthet Dermatol | 2026 | https://conductscience.org/library/papers/41648089 | PubMed |
| 41583477 | Aberrant B cell responses as drivers of autoantibody generation and epitope diversification in SLE pathogenesis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41583477 | PubMed |
| 41523142 | Cytokine Engineering in CAR-T Cell Therapy: Next-Generation Strategies. | Immune Netw | 2025 | https://conductscience.org/library/papers/41523142 | PubMed |
| 41460261 | Immunopathogenesis and Therapeutics of Systemic Lupus Erythematosus: an Integrative Review. | Clin Rev Allergy Immunol | 2025 | https://conductscience.org/library/papers/41460261 | PubMed |
| 41383631 | How artificial intelligence can enable personalized mesenchymal stem cell-based therapeutic strategies in systemic lupus erythematosus. | Front Immunol | 2025 | https://conductscience.org/library/papers/41383631 | PubMed |
| 41307598 | Chimeric Antigen Receptor T Cell Therapy in Systemic Lupus Erythematosus: Mechanisms, Clinical Advances, and Future Directions a Comprehensive Review. | Clin Rev Allergy Immunol | 2025 | https://conductscience.org/library/papers/41307598 | PubMed |
| 41305772 | Advances and prospects of CAR-T cell therapy in autoimmune disease treatment. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41305772 | PubMed |
| 41286216 | A bibliometric analysis on immunotherapy treatments for systemic lupus erythematosus: analysis of published evidence from 2014 to 2024. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/41286216 | PubMed |
| 41145295 | [Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | https://conductscience.org/library/papers/41145295 | PubMed |
| 41041324 | Innovations in immunotherapy for autoimmune diseases: recent breakthroughs and future directions. | Front Immunol | 2025 | https://conductscience.org/library/papers/41041324 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD19 | 930 | PubTator's text mining | https://conductscience.org/library/genes/930 | NCBI Gene |
| TNFRSF17 | 608 | PubTator's text mining | https://conductscience.org/library/genes/608 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39749335
GET https://conductscience.org/api/papers/v1/39749335/references?page=2